Free Trial

Insider Selling: GRAIL, Inc. (NASDAQ:GRAL) CFO Sells 8,000 Shares of Stock

GRAIL logo with Medical background

GRAIL, Inc. (NASDAQ:GRAL - Get Free Report) CFO Aaron Freidin sold 8,000 shares of GRAIL stock in a transaction that occurred on Tuesday, July 15th. The shares were sold at an average price of $38.93, for a total value of $311,440.00. Following the transaction, the chief financial officer owned 286,020 shares of the company's stock, valued at approximately $11,134,758.60. This represents a 2.72% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.

Aaron Freidin also recently made the following trade(s):

  • On Friday, May 2nd, Aaron Freidin sold 41,150 shares of GRAIL stock. The stock was sold at an average price of $33.93, for a total transaction of $1,396,219.50.

GRAIL Trading Down 1.9%

GRAL traded down $0.69 on Thursday, hitting $35.92. 990,154 shares of the company's stock were exchanged, compared to its average volume of 1,166,481. The firm has a 50-day moving average price of $41.82 and a 200-day moving average price of $33.96. The stock has a market cap of $1.29 billion and a price-to-earnings ratio of -0.59. GRAIL, Inc. has a fifty-two week low of $12.33 and a fifty-two week high of $63.99.

GRAIL (NASDAQ:GRAL - Get Free Report) last announced its quarterly earnings data on Tuesday, May 13th. The company reported ($3.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($4.03) by $0.93. GRAIL had a negative net margin of 1,464.53% and a negative return on equity of 17.99%. The company had revenue of $31.84 million during the quarter, compared to analysts' expectations of $35.80 million. On average, equities analysts predict that GRAIL, Inc. will post -15.15 EPS for the current year.

Institutional Investors Weigh In On GRAIL

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. State of Tennessee Department of Treasury purchased a new position in GRAIL during the fourth quarter worth about $28,000. Caldwell Sutter Capital Inc. purchased a new position in shares of GRAIL during the 1st quarter worth approximately $28,000. Sterling Capital Management LLC acquired a new stake in GRAIL in the 4th quarter valued at approximately $29,000. KBC Group NV lifted its stake in GRAIL by 187.7% during the first quarter. KBC Group NV now owns 1,430 shares of the company's stock worth $37,000 after purchasing an additional 933 shares in the last quarter. Finally, S.A. Mason LLC boosted its position in shares of GRAIL by 50.1% during the first quarter. S.A. Mason LLC now owns 1,499 shares of the company's stock worth $38,000 after buying an additional 500 shares during the period.

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group lifted their target price on shares of GRAIL from $32.00 to $43.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th.

View Our Latest Report on GRAIL

About GRAIL

(Get Free Report)

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.

Read More

Insider Buying and Selling by Quarter for GRAIL (NASDAQ:GRAL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in GRAIL Right Now?

Before you consider GRAIL, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GRAIL wasn't on the list.

While GRAIL currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It
NVDA Greenlight: China Sales Spark 50% Rally Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines